| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.089 | 0.05 |